Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation Impact of Conventional Oral Anticoagulant (OAC) Compared With Novel Oral Anticoagulant (NOAC)

NCT03187197 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03187197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03187197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation Impact of Conventional Oral Anticoagulant (OAC) Compared With Novel Oral Anticoagulant (NOAC)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
June 20, 2017
Completion date
January 11, 2019
Enrollment
1,315 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation